Stock Events

Stock Events

Achieve Life Sciences 

$8.49
80
+$0.18+2.17% 20:00 Today
-$0.10-1.2%21:06After hours

Statistics

Day High
8.55
Day Low
8.11
52W High
8.64
52W Low
2.62
Volume
872,763
Avg. Volume
1,801,392
Mkt Cap
873.64M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.8
-0.59
-0.38
-0.16
Expected EPS
-0.2
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-54.65MNet Income

Analyst Ratings

12.67Average Price Target
The highest estimate is 13.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ACHV. It's not an investment recommendation.
Amazon
13
AMZN
Apple
12
AAPL
Coca-Cola
12
KO
Microsoft
9
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is involved in developing treatments in various therapeutic areas, including smoking cessation aids which compete with Achieve Life Sciences' cytisinicline product.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline produces Nicorette, a nicotine replacement therapy, directly competing with Achieve's smoking cessation products.
Altria Group
MO
Mkt Cap114.63B
Altria Group, through its investments in nicotine replacement and cessation products, competes in the same market as Achieve Life Sciences.
British American Tobacco
BTI
Mkt Cap120.92B
British American Tobacco, with its investments in smoking cessation tools and nicotine replacement therapies, competes with Achieve Life Sciences.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its subsidiary producing Nicorette, competes in the nicotine replacement therapy market.
Novartis
NVS
Mkt Cap292.35B
Novartis offers smoking cessation products, which places it in direct competition with Achieve Life Sciences.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. competes through its research and development in therapies that could potentially include smoking cessation aids.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, with its broad interest in healthcare solutions, could potentially compete in the smoking cessation aid market.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries competes in the generic drug market, including potential production of smoking cessation aids.
22nd Century Group
XXII
Mkt Cap2.23M
22nd Century Group, Inc. specializes in tobacco products with reduced nicotine levels, indirectly competing with smoking cessation aids.

About

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Show more...
CEO
Andrew D. Goldberg
Employees
28
Country
United States
ISIN
US0044685008
WKN
000A2QAR3

Listings

XNAS
US
ACHV
STU
DE
SP4P.STU
MU
DE
SP4P.MU
F
DE
SP4P.F

0 Comments

Share your thoughts

FAQ

What is Achieve Life Sciences stock price today?▼
The current price of ACHV is $8.49 USD — it has increased by +2.17% in the past 24 hours. Watch Achieve Life Sciences stock price performance more closely on the chart.
What is Achieve Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Achieve Life Sciences stocks are traded under the ticker ACHV.
Is Achieve Life Sciences stock price growing?▼
ACHV stock has risen by +4.81% compared to the previous week, the month change is a +31.22% rise, over the last year Achieve Life Sciences has showed a +204.3% increase.
What is Achieve Life Sciences market cap?▼
Today Achieve Life Sciences has the market capitalization of 873.64M
When is the next Achieve Life Sciences earnings date?▼
Achieve Life Sciences is going to release the next earnings report on November 05, 2026.
What were Achieve Life Sciences earnings last quarter?▼
ACHV earnings for the last quarter are -0.8 USD per share, whereas the estimation was -0.16 USD resulting in a -385.2% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Achieve Life Sciences revenue for the last year?▼
Achieve Life Sciences revenue for the last year amounts to 0 USD.
What is Achieve Life Sciences net income for the last year?▼
ACHV net income for the last year is -54.65M USD.
How many employees does Achieve Life Sciences have?▼
As of September 04, 2026, the company has 28 employees.
In which sector is Achieve Life Sciences located?▼
Achieve Life Sciences operates in the Health & Wellness sector.
When did Achieve Life Sciences complete a stock split?▼
The last stock split for Achieve Life Sciences was on July 31, 2020 with a ratio of 1:20.
Where is Achieve Life Sciences headquartered?▼
Achieve Life Sciences is headquartered in SEATTLE, United States.